1. de JongK, NioC, MearadjiB, et al.Disappointing interobserver agreement among radiologists for a classifying diagnosis of pancreatic cysts using magnetic resonance imaging. Pancreas2012;41:278. CrossRef

2. LaffanTA, HortonKM, KleinAP, et al.Prevalence of unsuspected pancreatic cysts on MDCT. Am J Roentgenol2008;191:802. CrossRef

3. ValsangkarNP, MoralesOyarvideV, ThayerSP, et al.851 resected cystic tumors of the pancreas: a 33‐year experience at the Massachusetts General Hospital. Surgery2012;152:S4. CrossRef

4. CrippaS, SalviaR, WarshawAL, et al.Mucinous cystic neoplasm of the pancreas is not an aggessive entity: lessons from 163 resected patients. Ann Surg2008;247:571. CrossRef

5. YamaoK, YanagisawaA, TakahashiK, et al.Clinicopathological features and prognosis of mucinous cystic neoplasm with ovarian‐type stroma: a multi‐institutional study of the Japan Pancreas Society. Pancreas2011;40:67. CrossRef

6. Le BaleurY, CouvelardA, VulliermeMP, et al.Mucinous cystic neoplasms of the pancreas: definition of preoperative imaging criteria for high‐risk lesions. Pancreatology2011;11:495. CrossRef

7. ZamboniG, ScarpaA, BoginaG, et al.Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol1999;23:410. CrossRef

8. ThompsonLD, BeckerRC, PrzygodzkiRM, et al.Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low‐grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases. Am J Surg Pathol1999;23:1. CrossRef

9. BakerML, SeeleyES, PaiR, et al.Invasive mucinous cystic neoplasms of the pancreas. Exp Mol Pathol2012;93:345. CrossRef

10. TsengJF, WarshawAL, SahaniDV, et al.Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg2005;242:413, discussion 9‐21.

11. Le BorgneJ, de CalanL, PartenskyC. atFSA. Cystadenomas and cystadenocarcinomas of the pancreas: a mulatiinstitutional restrospective study of 398 cases. Ann Surg1999;230:152. CrossRef

12. JimenezRE, WarshawAL, Z'GraggenK, et al.Sequential accumulation of K‐ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy. Ann Surg1999;230:501, discussion 9‐11. CrossRef

13. Iacobuzio‐DonahueCA, WilentzRE, ArganiP, et al.Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression. Am J Surg Pathol2000;24:1544. CrossRef

14. WuJ, JiaoY, Dal MolinM, et al.Whole‐exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin‐dependent pathways. Proc Natl Acad Sci U S A2011;108:21188. CrossRef

15. IzumoA, YamaguchiK, EguchiT, et al.Mucinous cystic tumor of the pancreas: immunohistochemical assessment of “ovarian‐type stroma”. Oncol Rep2003;10:515.

16. O'TooleD, PalazzoL, HammelP, et al.Macrocystic pancreatic cystadenoma: the role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesions. Gastrointest Endosc2004;59:823. CrossRef

17. BruggeWR, LewandrowskiK, Lee‐LewandrowskiE, et al.Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology2004;126:1330. CrossRef

18. TanakaM, Fernández‐del CastilloC, AdsayV, et al.International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology2012;12:183. CrossRef

19. GalanisC, ZamaniA, CameronJL, et al.Resected serous cystic neoplasms of the pancreas: a review of 158 patients with recommendations for treatment. J Gastrointest Surg2007;11:820. CrossRef

20. BassiC, SalviaR, MolinariE, et al.Management of 100 consecutive cases of pancreatic serous cystadenoma: wait for symptoms and see at imaging or vice versa?World J Surg2003;27:319. CrossRef

21. HochwaldSN, RofskyNM, DobryanskyM, et al.Magnetic resonance imaging with magnetic resonance cholangiopancreatography accurately predicts resectability of pancreatic carcinoma. J Gastrointest Surg1999;3:506. CrossRef

22. KimuraW, MoriyaT, HiraiI, et al.Multicenter study of serous cystic neoplasm of the Japan pancreas society. Pancreas2012;41:380. CrossRef

23. KingJC, NgTT, WhiteSC, et al.Pancreatic serous cystadenocarcinoma: a case report and review of the literature. J Gastrointest Surg2009;13:1864. CrossRef

24. KhashabMA, ShinEJ, AmateauS, et al.Tumor size and location correlate with behavior of pancreatic serous cystic neoplasms. Am J Gastroenterol2011;106:1521. CrossRef

25. MalleoG, BassiC, RossiniR, et al.Growth pattern of serous cystic neoplasms of the pancreas: observational study with long‐term magnetic resonance surveillance and recommendations for treatment. Gut2012;61:746. CrossRef

26. HwangHK, KimH, KangCM, et al.Serous cyst adenoma of the pancreas: appraisal of active surgical strategy before it causes problems. Surg Endosc2012;26:1560. CrossRef

27. MenardA, TomlinsonG, ClearyS, et al.Serous cystadenomas of the pancreas: long‐term follow‐up measurement of growth rate. Can Assoc Radiol J2011;62:190. CrossRef

28. ImaokaH, YamaoK, SalemAA, et al.Pancreatic endocrine neoplasm can mimic serous cystadenoma. Int J Gastrointest Cancer2005;35:217. CrossRef

29. SaharaS, KawaiN, SatoM, et al.Differentiation of pancreatic serous cystadenoma from endocrine tumor and intraductal papillary mucinous neoplasm based on washout pattern on multiphase CT. J Comput Assist Tomogr2012;36:231. CrossRef

30. HayashiK, FujimitsuR, IdaM, et al.CT differentiation of solid serous cystadenoma vs endocrine tumor of the pancreas. Eur J Radiol2012;81:e203. CrossRef

31. GerkeH, SilvaR, JensenCS. Hypervascular pancreatic tumor diagnosed as a serous cystadenoma by EUS‐guided Trucut biopsy. Gastrointest Endosc2006;64:273. CrossRef

32. HammelPR, VilgrainV, TerrisB, et al.Pancreatic involvement in von Hippel‐Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel‐Lindau. Gastroenterology2000;119:1087. CrossRef

33. CharlesworthM, VerbekeCS, FalkGA, et al.Pancreatic lesions in von Hippel‐Lindau disease? A systematic review and meta‐synthesis of the literature. J Gastrointest Surg2012;16:1422. CrossRef

34. PanarelliNC, ParkKJ, HrubanRH, et al.Microcystic serous cystadenoma of the pancreas with subtotal cystic degeneration: another neoplastic mimic of pancreatic pseudocyst. Am J Surg Pathol2012;36:726. CrossRef

35. MoorePS, ZamboniG, BrighentiA, et al.Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppressor gene on chromosome 10q. Am J Pathol2001;158:317. CrossRef

36. ThirabanjasakD, BasturkO, AltinelD, et al.Is serous cystadenoma of the pancreas a model of clear‐cell‐associated angiogenesis and tumorigenesis?Pancreatology2009;9:182. CrossRef

37. VassosN, AgaimyA, KleinP, et al.Solid‐pseudopapillary neoplasm (SPN) of the pancreas: case series and literature review on an enigmatic entity. Int J Clin Exp Pathol2013;6:1051.

38. PapavramidisT, PapavramidisS. Solid pseudopapillary tumors of the pancreas: review of 718 patients reported in English literature. J Am Coll Surg2005;200:965. CrossRef

39. ReddyS, CameronJL, ScudiereJ, et al.Surgical management of solid‐pseudopapillary neoplasms of the pancreas (Franz or Hamoudi tumors): a single‐institutional series. J Am Coll Surg2009;208:950. CrossRef

40. ButteJM, BrennanMF, GonenM, et al.Solid pseudopapillary tumors of the pancreas. Clinical features, surgical outcomes, and long‐term survival in 45 consecutive patients from a signle center. J Gastrointest Surg 20112011;15:350. CrossRef

41. SerraS, ChettyR. Revision 2: an immunohistochemical approach and evaluation of solid pseudopapillary tumour of the pancreas. J Clin Pathol2008;61:1153. CrossRef

42. El‐BahrawyMA, RowanA, HorncastleD, et al.E‐cadherin/catenin complex status in solid pseudopapillary tumor of the pancreas. Am J Surg Pathol2008;32:1. CrossRef

43. TanakaY, KatoK, NotoharaK, et al.Frequent beta‐catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid‐pseudopapillary neoplasm. Cancer Res2001;61:8401.

44. ChettyR, SerraS. Loss of expression of E‐cadherin in solid pseudopapillary tumors of the pancreas. Pancreas2009;38:338, author reply ‐9. CrossRef

45. AbrahamSC, KlimstraD, WilentzRE, et al.Solid‐pseudopapillary tumors of teh pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta‐catenin mutations. Am J Pathol2002;160:1361. CrossRef

46. GeersC, MoulinP, GigotJF, et al.Solid and pseudopapillary tumor of the pancreas–review and new insights into pathogenesis. Am J Surg Pathol2006;30:1243. CrossRef

47. MoralesA, Ruiz MolinaJM, EstevesHO, et al.Papillary‐cystic neoplasm of the pancreas. A sex‐steroid dependent tumor. Int J Pancreatol1998;24:219.

48. FriedP, CooperJ, BalthazarE, et al.A role for radiotherapy in the treatment of solid and papillary neoplasms of the pancreas. Cancer1985;56:2783. CrossRef

49. GaujouxS, TangL, KlimstraD, et al.The outcome of resected cystic pancreatic endocrine neoplasms: a case‐matched analysis. Surgery2012;151:518. CrossRef

50. BoninsegnaL, PartelliS, D'InnocenzioMM, et al.Pancreatic cystic endocrine tumors: a different morphological entity associated with a less aggressive behavior. Neuroendocrinology2010;92:246. CrossRef

51. BordeianouL, VagefiPA, SahaniDV, et al.Cystic pancreatic endocrine neoplams: a distinct tumor type?J Am Coll Surg2008;206:1154. CrossRef

52. FederleMP, McGrathKM. Cystic neoplasms of the pancreas. Gastroenterol Clin North Am2007;36:365, ix. CrossRef

53. SinghiAD, ChuLC, TatsasAD, et al.Cystic pancreatic neuroendocrine tumors: a clinicopathologic study. Am J Surg Pathol2012;36:1666. CrossRef

54. HoHC, EloubeidiMA, SiddiquiUD, et al.Endosonographic and cyst fluid characteristics of cystic pancreatic neuroendocrine tumours: a multicentre case series. Dig Liver Dis2013;45:750. CrossRef

55. LigneauB, Lombard‐BohasC, PartenskyC, et al.Cystic endocrine tumors of the pancreas: clinical, radiologic, and histopathologic features in 13 cases. Am J Surg Pathol2001;25:752. CrossRef

56. KongkamP, Al‐HaddadM, AttasaranyaS, et al.EUS and clinical characteristics of cystic pancreatic neuroendocrine tumors. Endoscopy2008;40:602. CrossRef

57. GohBK, OoiLL, TanYM, et al.Clinico‐pathological features of cystic pancreatic endocrine neoplasms and a comparison with their solid counterparts. Eur J Surg Oncol2006;32:553. CrossRef

58. YoonWJ, DaglilarES, PitmanMB, et al.Cystic pancreatic neuroendocrine tumors: endoscopic ultrasound and fine‐needle aspiration characteristics. Endoscopy2013;5:189.

59. DavtyanH, NiebergR, ReberHA. Pancreatic cystic endocrine neoplasms. Pancreas1990;5:230. CrossRef

60. KamisawaT, FukayamaM, KoikeM, et al.A case of malignant cystic endocrine tumor of the pancreas. Am J Gastroenterol1987;82:86.

61. Fernandez‐del CastilloC, WarshawAL. Cystic tumors of the pancreas. Surg Clin North Am1995;75:1001.

62. LeeLC, GrantCS, SalomaoDR, et al.Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management. Surgery2012;152:965. CrossRef

63. Fernández‐del CastilloC, AdsayNV. Intraductal papillary mucinous neooplasms of the pancreas. Gastroenterology2010;139:708. CrossRef

64. AdsayNV, ConlonKC, ZeeSY, et al.Intraductal papillary‐mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer2002;94:62. CrossRef

65. FukushimaN, MukaiK, SakamotoM, et al.Invasive carcinoma derived from intraductal papillary‐mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases. Virchows Arch2001;439:6. CrossRef

66. KloppelG. Clinicopathologic view of intraductal papillary‐mucinous tumor of the pancreas. Hepatogastroenterology1998;45:1981.

67. CuillerierE, CellierC, PalazzoL, et al.Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas. Am J Gastroenterol2000;95:441. CrossRef

68. CrippaS, Fernández‐del CastilloC, SalviaR, et al.Mucin‐producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol2010;8:213. CrossRef

69. FurukawaT, HatoriT, FujitaI, et al.Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut2011;60:509. CrossRef

70. FarrellJJ, Fernandez‐del CastilloC. Pancreatic cystic neoplasms: management and unanswered questions. Gastroenterology2013;144:1303. CrossRef

71. SohnTA, YeoCJ, CameronJL, et al.Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg2004;239:788, discussion 97‐9. CrossRef

72. MaguchiH, TannoS, MizunoN, et al.Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan. Pancreas2011;40:364. CrossRef

73. LevyP, JouannaudV, O'TooleD, et al.Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy. Clin Gastroenterol Hepatol2006;4:460. CrossRef

74. WasifN, BentremDJ, FarrellJJ, et al.Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage‐matched comparison of outcomes. Cancer2010;116:3369. CrossRef

75. AdsayNV, MeratiK, BasturkO, et al.Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an “intestinal” pathway of carcinogenesis in the pancreas. Am J Surg Pathol2004;28:839. CrossRef

76. PoultsidesGA, ReddyS, CameronJL, et al.Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm‐associated invasive adenocarcinoma of the pancreas. Ann Surg2010;251:470. CrossRef

77. Mino‐KenudsonM, Fernández‐del CastilloC, BabaY, et al.Prognosis of invasive IPMN depends on histological and precursor epithelial subtypes. Gut2011;60:1712. CrossRef

78. LuttgesJ, ZamboniG, LongneckerD, et al.The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol2001;25:942. CrossRef

79. FurukawaT, KlöppelG, AdsayNV, et al.Classification of types of intraductal papillary‐mucinous neoplasm of the pancreas: a consensus study. Virchows Arch2005;447:794. CrossRef

80. SadakariY, OhuchidaK, NakataK, et al.Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type. Surgery2010;147:812. CrossRef

81. StrobelO, RosowDE, RakhlinEY, et al.Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh‐induced metaplasia. Gastroenterology2010;138:1166. [Epub 2009 Dec 21]. CrossRef

82. CantoMI, HrubanRH, FishmanEK, et al.Frequent detection of pancreatic lesions in asymptomatic high‐risk individuals. Gastroenterology2012;142:796. CrossRef

83. HrubanRH, AdsayNV, Albores‐SaavedraJ, et al.Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol2001;25:579. CrossRef

84. BasturkO, KhayyataS, KlimstraDS, et al.Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway, distinct from the intestinal pathway, in pancreatic carcinogenesis. Am J Surg Pathol2010;34:364. CrossRef

85. PatelSA, AdamsR, GoldsteinM, et al.Genetic analysis of invasive carcinoma arising in intraductal oncocytic papillary neoplasm of the pancreas. Am J Surg Pathol2002;26:1071. CrossRef

86. TajiriT, TateG, KunimuraT, et al.Histologic and immunohistochemical comparison of intraductal tubular carcinoma, intraductal papillary‐mucinous carcinoma, and ductal adenocarcinoma of the pancreas. Pancreas2004;29:116. CrossRef

87. KandaM, SadakariY, BorgesM, et al.Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high‐grade dysplasia. Clin Gastroenterol Hepatol2013;11:719. CrossRef

88. XiaoHD, YamaguchiH, Dias‐SantagataD, et al.Molecular characteristics and biological behaviours of the oncocytic and pancreatobiliary subtypes of intraductal papillary mucinous neoplasms. J Pathol2011;224:508. CrossRef

89. WuJ, MatthaeiH, MaitraA, et al.Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med2011;3:92.

90. Dal MolinM, MatthaeiH, WuJ, et al.Clinicopathological correlates of activating gnas mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg Oncol2013;20:3802. CrossRef

91. MatthaeiH, NorrisAL, TsiatisAC, et al.Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg2012;255:326. CrossRef

92. HongSM, OmuraN, VincentA, et al.Genome‐wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res2012;18:700. CrossRef

93. HongSM, VincentA, KandaM, et al.Genome‐wide somatic copy number alterations in low‐grade PanINs and IPMNs from individuals with a family history of pancreatic cancer. Clin Cancer Res2012;18:4303. CrossRef

94. HabbeN, KoorstraJB, MendellJT, et al.MicroRNA miR‐155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther2009;8:340. CrossRef

95. FarrellJJ, TosteP, WuN, et al.Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer. Am J Gastroenterol2013;108:1352. CrossRef

96. MatthaeiH, WylieD, LloydMB, et al.miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res2012;18:4713. CrossRef

97. ReboursV, CouvelardA, PeyrouxJL, et al.Familial intraductal papillary mucinous neoplasms of the pancreas. Dig Liver Dis2012;44:442. CrossRef

98. IngkakulT, ThayerSP, FerroneCR, et al.Epidemiology of intraductal papillary mucinous neoplasms of the pancreas: gender differences between 3 geographic regions. Pancreas2011;40:779. CrossRef

99. HaraH, SudaK, OyamaT. Cytologic study of noninvasive intraductal papillary‐mucinous carcinoma of the pancreas. Acta Cytol2002;46:519. CrossRef

100. KuriharaK, NagaiH, KasaharaK, et al.Biliopancreatic fistula associated with intraductal papillary‐mucinous pancreatic cancer: institutional experience and review of the literature. Hepatogastroenterology2000;47:1164.

101. YamaguchiKKS, HatoriT, MaguchiH, et al.Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas2011;40:571. CrossRef

102. IdenoN, OhtsukaT, KonoH, et al.Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ann Surg2013;258:141. CrossRef

103. Correa‐GallegoC, FerroneCR, ThayerSP, et al.Incidental pancreatic cysts: do we really know what we are watching?Pancreatology2010;10:144. CrossRef

104. TanakaM, ChariS, AdsayV, et al.International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology2006;6:17. CrossRef

105. FritzS, SchirrenM, KlaussM, et al.Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas. Surgery2012;152(3 Suppl 1):S74. CrossRef

106. WongJ, WeberJ, CentenoBA, et al.High‐grade dysplasia and adenocarcinoma are frequent in side‐branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound. J Gastrointest Surg2013;17:78, discussion p ‐5. CrossRef

107. TangRS, WeinbergB, DawsonDW, et al.Evaluation of the guidelines for management of pancreatic branch‐duct intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol2008;6:815, quiz 719. CrossRef

108. RodriguezJR, SalviaR, CrippaS, et al.Branch‐duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology2007;133:72, quiz 309‐10. CrossRef

109. Pelaez‐LunaM, ChariST, SmyrkTC, et al.Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol2007;102:1759. CrossRef

110. WeinbergBM, SpiegelBM, TomlinsonJS, et al.Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov‐based clinical nomograms. Gastroenterology2010;138:531. CrossRef

111. TannoS, NakanoY, NishikawaT, et al.Natural history of branch duct intraductal papillary‐mucinous neoplasms of the pancreas without mural nodules: long‐term follow‐up results. Gut2008;57:339. CrossRef

112. MoriY, OhtsukaT, KonoH, et al.Management strategy for multifocal branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreas2012;41:1008. CrossRef

113. BerlandLL, SilvermanSG, GoreRM, et al.Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol2010;7:754. CrossRef

114. NehraD, OyarvideVM, Mino‐KenudsonM, et al.Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter. Pancreatology2012;12:358. CrossRef

115. KangMJ, JangJY, KimSJ, et al.Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. Clin Gastroenterol Hepatol2011;9:87. CrossRef

116. MillerJR, MeyerJE, WatersJA, et al.Outcome of the pancreatic remnant following segmental pancreatectomy for non‐invasive intraductal papillary mucinous neoplasm. HPB (Oxford)2011;13:759. CrossRef

117. KhannoussiW, VulliermeMP, ReboursV, et al.The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology2012;12:198. CrossRef

118. OsiroS, RodriguezJR, TiwariKJ, et al.Is preoperative diagnosis possible? A clinical and radiological review of lymphoepithelial cysts of the pancreas. JOP2013;14:15.

119. NasrJ, SandersM, FasanellaK, et al.Lymphoepithelial cysts of the pancreas: an EUS case series. Gastrointest Endosc2008;68:170. CrossRef

120. CoeA, ConwayJ, EvansJ, et al.The yield of EUS‐FNA in undiagnosed upper abdominal adenopathy is very high. J Clin Ultrasound2013;41:210. CrossRef

121. JathalA, ArsenescuR, CroweG, et al.Diagnosis of pancreatic cystic lymphangioma with EUS‐guided FNA: report of a case. Gastrointest Endosc2005;61:920. CrossRef

122. BhatiaV, RastogiA, SalujaSS, et al.Cystic pancreatic lymphangioma. The first report of a preoperative pathological diagnosis by endoscopic ultrasound‐guided cyst aspiration. JOP2011;12:473.

123. PaikKY, ChoiSH, HeoJS, et al.Solid tumors of the pancreas can put on a mask through cystic change. World J Surg Oncol2011;9:79. CrossRef

124. SahaniDV, LinDJ, VenkatesanAM, et al.Multidisciplinary approach to diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas. Clin Gastroenterol Hepatol2009;7:259. CrossRef

125. ChaudhariVV, RamanSS, VuongNL, et al.Pancreatic cystic lesions: discrimination accuracy based on clinical data and high resolution CT features. J Comput Assist Tomogr2007;31:860. CrossRef

126. KimJH, EunHW, ParkHJ, et al.Diagnostic performance of MRI and EUS in the differentiation of benign from malignant pancreatic cyst and cyst communication with the main duct. Eur J Radiol2012;81:2927. CrossRef

127. LeeLS, SaltzmanJR, BoundsBC, et al.EUS‐guided fine needle aspiration of pancreatic cysts: a retrospective analysis of complications and their predictors. Clin Gastroenterol Hepatol2005;3:231. CrossRef

128. PitmanMB, GenevayM, YaegerK, et al.High‐grade atypical epithelial cells in pancreatic mucinous cysts are a more accurate predictor of malignancy than “positive” cytology. Cancer Cytopathol2010;118:434. CrossRef

129. van der WaaijLA, van DullemenHM, PorteRJ. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc 20052005;62:383. CrossRef

130. OthmanMO, PatelM, DabizziE, et al.Carcino Embryonic Antigen and long‐term follow‐up of mucinous pancreatic cysts including intraductal papillary mucinous neoplasm. Dig Liver Dis2012;44:844. CrossRef

131. Al‐HaddadM, DewittJ, ShermanS, et al.Performance characteristics of molecular (DNA) analysis for the diagnosis of mucinous pancreatic cysts. Gastrointest Endosc2014;79:79. CrossRef

132. SiddiquiAA, KowalskiTE, KedikaR, et al.EUS‐guided pancreatic fluid aspiration for DNA analysis of KRAS and GNAS mutations for the evaluation of pancreatic cystic neoplasia: a pilot study. Gastrointest Endosc2013;77:669. CrossRef

133. RockacyMJ, ZahidM, McGrathKM, et al.Association between KRAS mutation, detected in pancreatic cyst fluid, and long‐term outcomes of patients. Clin Gastroenterol Hepatol2013;11:425. CrossRef

134. MertzH. K‐ras mutations correlate with atypical cytology and elevated CEA levels in pancreatic cystic neoplasms. Dig Dis Sci2011;56:2197. CrossRef

135. TollAD, KowalskiT, LorenD, et al.The added value of molecular testing in small pancreatic cysts. JOP2010;11:582.

136. ShenJBW, DimaioCJ, PitmanMB. Molecular analysis of pancreatic cyst fluid: a comparative analysis with current practice of diagnosis. Cancer2009;117:217.

137. SreenarasimhaiahJ, LaraLF, JazrawiSF, et al.A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts. JOP2009;10:163.

138. SawhneyMSDS, O'FarrelP, CuryMS, et al.Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid. Gastrointest Endosc2009;69:1106. CrossRef

139. KhalidA, ZahidM, FinkelsteinSD, et al.Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc2009;69:1095. CrossRef

140. GanSI, ThompsonCC, LauwersGY, et al.Ethanol lavage of pancreatic cystic lesions: initial pilot study. Gastrointest Endosc2005;61:746. CrossRef

141. OhHC, SeoDW, SongTJ, et al.Endoscopic ultrasonography‐guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts. Gastroenterology2011;140:172. CrossRef

142. OhHC, BruggeWR. EUS‐guided pancreatic cyst ablation: a critical review (with video). Gastrointest Endosc2013;77:526. CrossRef

143. OhHC, SeoDW. Ablate under EUS‐guidance when properly indicated. Gastroenterology2011;141:e20.

144. OhHC, SeoDW, LeeTY, et al.New treatment for cystic tumors of the pancreas: EUS‐guided ethanol lavage with paclitaxel injection. Gastrointest Endosc2008;67:636. CrossRef

145. DeWittJ, McGreevyK, SchmidtCM, et al.EUS‐guided ethanol versus saline solution lavage for pancreatic cysts: a randomized, double‐blind study. Gastrointest Endosc2009;70:710. CrossRef

146. SalviaR, BassiC, FalconiM, et al.Intraductal papillary mucinous tumors of the pancreas. Surgical treatment: at what point should we stop?JOP2005;6(1 Suppl):112.

147. GaujouxS, BrennanMF, GonenM, et al.Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15‐year time period. J Am Coll Surg2011;212:590. CrossRef